How many clinical trials are tracked of PLX3397?

7 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Dermatology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

PLX3397

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of PLX3397

7 trials tracked of PLX3397.

7Trials tracked

0Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 2 4 Phase 1 2 Other / NA 1

Phase 2 A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma Completed
Phase 2 Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML) Completed
Phase 2 Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer Completed
Phase 2 Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma Completed
Phase 1 Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors Completed
Phase 1 Safety Study of PLX108-01 in Patients With Solid Tumors Completed

Show 1 more trials

N/A A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.